+918048067265
Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.
Now long term survival is possible in some stage IV solid cancers with the use of targeted, hormonal, chemotherapy drugs. The list includes:1) Stage IV hormone receptor positive metastatic breast cancer.2) Stage IV her2 nu positive metastatic breas
View DetailsSoon in india 2 different CDK 4/6 inhibitors will be available thus widening treatment options for hormone positive metastatic breast cancer.CDK 4/6 inhibitors are new class of drugs recently approved for metastatic hormone positive breast cancer
View DetailsIs it possible to avoid chemotherapy in Breast Cancer?Breast cancer is a heterogeneous disease.This heterogeneity was initially assessed by clinical factors comprising of age, stage, grade, hormone-her2nu status and presence or absence of lymphov
View DetailsERA OF PERSONALISED MEDICINE IN METASTATIC ADENOCARCINOMA LUNG:Stage IV adenocarcinoma is not a single disease. Different molecular subtypes of NSCLC have been identified and the treatment approach is different for each subtype.The different mole
View DetailsMedian survival in metastatic carcinoma breast is 2 years.5 year survival is close to 25% (i.e. one out of 4 patients of metastatic breast cancer will be alive at 5 years).New Class of drugs - CDK4 & 6 inhibitor (Palbociclib, Ribociclib) have bee
View DetailsA awareness video on Head and Neck Cancers:https://youtu.be/NiAvJGozF8A
View DetailsPregnancy and cancer: A challenge for obstetrician and oncologist!As the age of child birth is delayed we may be seeing more cases with cancer in pregnancy.At present estimated incidence of cancer in pregnancy is estimated to be around 1 in 1000
View DetailsHappy to share our article- "MRD negative CR after azacitidine and venetoclax in a young patient with AML, unfit for intensive induction followed by ASCT" published in the international journal, Leukemia Research Reports.article link:https://doi.or
View Details